findmyKOL
Clinical trialNCT00364676CompletedPhase 1Interventional

Study of Vinorelbine Liposomes Injection for Advanced Solid Tumors, Non-Hodgkin's Lymphoma or Hodgkin's Disease

SponsorSpectrum Pharmaceuticals, IncEnrollment67Hodgkins DiseaseNon-Hodgkins LymphomaTumors
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

  • Anthony W. Tolcher, MD

    South Texas Accelerated Research Therapeutics

    Principal Investigator
  • Gerald Batist, MD

    McGill Centre for Translational Research in Cancer-Jewish General Hospital Clinical Research Unit

    Principal Investigator
  • John Sarantopoulos, MD

    Cancer Therapy and Research Center, Texas

    Principal Investigator

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

3 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Canada
  • Mcgill Centre for Translational Research in Cancer-Jewish General Hospital Clinical Research Unit

    Montreal, Quebec, Canada

United States
  • Cancer Therapy and Research Center

    San Antonio, Texas, United States

  • South Texas Accelerated Research Therapeutics

    San Antonio, Texas, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
31 Jul 2006
Primary completion
30 Jun 2015
Completion
31 Aug 2015
Last update posted
22 Sept 2015
Registered enrollment
67
Registry id
NCT00364676

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.